Biogen (BIIB) Q4 Earnings Miss, Revenues Surpass Estimates

Biogen Inc. BIIB reported fourth-quarter 2020 earnings per share of $4.58, which missed the Zacks Consensus Estimate of $4.93. Earnings declined 45.1% year over year due to lower revenues.Biogen Inc. BIIB reported fourth-quarter 2020 earnings per share of $4.58, which missed the Zacks Consensus Estimate of $4.93. Earnings declined 45.1% year over year due to lower revenues.Read MoreStocks,InvestingStocks Feed